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CytotoxicityAbstract The octahedral ruthenium(II) complexes [Ru(Ln)(PPh3)2Cl2] [L
n = biphenyl furanyl
pyridine derivatives] were synthesized and characterized using LC–MS, IR spectroscopy, elemental
analysis and magnetic measurements. Complexes show enhancement in antibacterial activity
compared to free ligands. From the binding mode investigation by absorption titration and
viscosity measurement, it is observed that complexes bind to DNA via intercalation and also
complexes promote the cleavage of supercoiled pUC19 plasmid DNA. Cytotoxicity analysis shows
100% mortality of Brine shrimp after 48 h.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Recently, metal complexes as DNA interacting agents have
been talk in medicinal inorganic chemistry (Fei et al., 2014;
Zhao et al., 2011; Abou-Hussen and Linert, 2009; Patel,
2004; Wu et al., 2011; Khan et al., 2014). DNA intrastrand
cross-linking agents are found useful in treatment of cancers,
psoriasis and various anemias. Several ruthenium complexes
have been developed as an alternative to cis-platin as potential
anticancer agents with lower toxicity than the platinum coun-
terparts (Clarke and Keppler, 1993; Keppler et al., 1993;
Clarke et al., 1999; Sava and Bergamo, 2000). Large interest
has been drawn toward the interaction of Ru(II) complexescontaining planar polycyclic hetero aromatic ligands (Ji
et al., 2001). Studies on DNA-binding of the complexes are
crucial in development of nucleic acid interaction, chemother-
apy and photodynamic treatment (Huppert, 2008;
Balasubramanian and Neidle, 2009; Georgiades et al., 2010).
Recently, ruthenium(II) polypyridyl complexes have been
found to induce apoptosis in A549 cells (Bing-Jie et al.,
2014). Also, the main ligands of Ru(II)–polypyridyl complexes
possess extended conjugated planar aromatic structures can
insert and stack between the base pairs of DNA.
Considerable effects are observed in the binding mode, sites
and afﬁnities upon slight changes in the molecular structures
of Ru(II) complexes which provide the opportunity to discover
important information on site-speciﬁc DNA probes.
Therefore, studies on modifying the main ligand is quite signif-
icant for understanding the optical properties of DNA-binding
and action mechanism of ruthenium complexes.
In continuation of our earlier work (Patel et al., 2014),
biological activity of the synthesized complexes was carried
out by performing antibacterial, DNA binding, DNA cleavage
and cytotoxicity study..doi.org/
2 M.N. Patel et al.2. Experimental
2.1. Reagents and materials
All the chemicals were of analytical grade. Ruthenium chloride
trihydrate, 2-acetylfuran, 4-chlorobenzaldehyde, 4-ﬂuoro-
bezaldehyde, 4-bromobezaldehyde, 3-chlorobenzaldehye, 3-
ﬂuorobezaldehyde and 3-bromobezaldehyde were purchased
from Sigma Chemical Co. (India). Ethidium bromide (EB),
bromophenol blue, agarose and Luria Broth (LB) were pur-
chased from Himedia (India). Culture of pUC19 bacteria
(MTCC 47) was purchased from Institute of Microbial
Technology (Chandigarh, India).
2.2. Physical measurements
Perkin–Elmer 240 Elemental Analyzer was used to collect
micro analytical data. Room temperature magnetic susceptibil-
ity was measured by Gouy’s method. FT–IR data were col-
lected by FT–IR ABB Bomen MB 3000 spectrophotometer.
The 1H NMR and 13C NMR were recorded on a Bruker
Avance (400 MHz). UV–Vis spectra of the complexes were
recorded on UV-160A UV–Vis spectrophotometer, Shimadzu
(Japan). Cleavage of pUC19 DNA was quantiﬁed by
AlphaDigiDoc RT. Version V.4.0.0.
2.3. Synthesis of ligands
Modiﬁcation of Krohnke pyridine synthesis (Krohnke, 1976)
has been used for the synthesis of ligands [L1–L6] (Scheme 1).Scheme 1 General reaction schem
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tolylpyridine [L1]
Substituted enone synthesized by the reaction of p-
ﬂuorobenzaldehyde and p-methylacetophenone, was reﬂuxed
with pyridinium salt of 2-acetylfuran in presence of ammo-
nium acetate for 6 h. The reaction mixture was allowed to cool
at room temperature. The solid product was ﬁltered and
recrystallized from hexane. Yield: 53%, mp: 118 C, Anal.
Calc. for C22H16FNO (329.37): Calc. (%): C, 80.23; H, 4.90;
N, 4.25. Found (%): C, 80.21; H, 4.93; N, 4.27. 1H NMR
(CDCl3, 400 MHz): d (ppm) 8.068–8.064 (d-poor resolved,
2H, H200,600), 7.823–7.819 (d, 1H, H3), 7.765–7.730 (complex,
3H, H5,300,500), 7.590–7.584 (dd-poor resolved, 1H, H50), 7.345–
7.325 (d, 2H, H3000 ;5000 ), 7.284–7.209 (complex, 3H, H40 ;2000 ;60 ),
6.606–6.593 (dd, 1H, H30), 2.456 (s, 3H, ACH3). IR (KBr,
4000–400 cm1): 3032, v(CAH)ar stretching; 1543, v(C‚C); 1497,
v(C‚N); 1304, pyridine skeleton band; 1220, v(CAF); 918,
818, (p-substituted ring); 740, v(CAH)ar bending.
13C NMR
(CDCl3, 100 MHz) d (ppm): 157.19 (C400), 155.83 (C2), 149.96
(C6,20), 143.04 (C4), 139.37 (C50), 136.88 (C100), 131.48 (C1000 ),
129.44 (C200 ;600 ;4000 ), 128.14 (C3000 ;5000 ), 124.12 (C3;2000 ;6000 ), 116.41
(C30), 114.78 (C300,500), 112.25 (C5), 109.07 (C40), 20.53 ACH3.
2.3.2. Synthesis of 4-(4-chlorophenyl)-2-(furan-2-yl)-6-p-
tolylpyridine [L2]
It has been synthesized using pyridinium salt of 2-acetyl furan
and the enone prepared by the reaction between p-
chlorobenzaldehyde and p-methylacetophenone. Yield: 59%,
mp: 110 C, Anal. Calc. for C22H16ClNO (345.82): Calc. (%):
C, 76.41; H, 4.66; N, 4.05. Found (%): C, 76.44; H, 4.67; N,
4.08. 1H NMR (CDCl3, 400 MHz): d (ppm) 8.064–8.044 (dd,e for the synthesis of ligands.
nds and its applications. Arabian Journal of Chemistry (2015), http://dx.doi.org/
Synthesis and applications of heterocyclic compounds 32H, H200,600), 7.823–7.821 (dd, 1H, H50), 7.757 (s, 1H, H3),
7.714–7.693 (d, 2H, H3000 ;5000 ), 7.588 (s, 1H, H5), 7.524–7.503
(d, 2H, H300,500), 7.345–7.325 (d, 2H, H2000 ;6000 ), 7.284–7.271 (dd,
1H, H40), 6.606–6.594 (dd, 1H, H30), 2.456 (s, 3H, –CH3). IR
(KBr, 4000–400 cm1): 3063, v(CAH)ar stretching; 1543,
v(C‚C); 1489, v(C‚N); 1327, pyridine skeleton band; 1040,
v(CACl); 987, 810, (p-substituted ring) 733, v(CAH)ar bending.
13C NMR (CDCl3, 100 MHz) d (ppm): 156.52 (C400), 154.13
(C2), 150.83 (C20), 144.66 (C6), 139.89 (C4), 138.54 (C50),
136.11 (C100 ;1000 ), 132.60 (C200;600;4000 ), 130.22 (C3;3000 ;5000 ), 128.61
(C2000 ;6000 ), 126.40 (C300,500), 124.08 (C5), 117.52 (C40), 115.91
(C30), 20.66 ACH3.
2.3.3. Synthesis of 4-(4-bromophenyl)-2-(furan-2-yl)-6-p-
tolylpyridine [L3]
It has been synthesized using the pyridinium salt of 2-acetyl
furan and enone prepared by the reaction between p-
bromobenzaldehyde and p-methylacetophenone. Yield: 49%,
mp: 130 C, Anal. Calc. for C22H16BrNO (390.27): Calc. (%):
C, 67.71; H, 4.13; N, 3.59. Found (%): C, 67.74; H, 4.17; N,
3.61. 1H NMR (CDCl3, 400 MHz): d (ppm) 8.071–8.051 (d,
2H, H200,600), 7.968–7.948 (dd, 1, H50), 7.831 (s, 1H, H3), 7.792
(s, 1H, H5), 7.580–7.539 (t, 3H2000 ;3000 ;6000 ), 7.500 (s poor resolved,
1H, H5000 ), 7.335–7.240 (complex, 3H, H40,300,500), 6.607–6.597
(dd, 1H, H30), 2.420 (s, 3H, ACH3). IR (KBr, 4000–
400 cm1): 3044, v(CAH)ar stretching; 1543, v(C‚C); 1427,
v(C‚N); 1373, pyridine skeleton band; 1050, v(CABr); 920,
818, (p-substituted ring); 771, v(CAH)ar bending.
13C NMR
(CDCl3, 100 MHz) d (ppm): 157.64 (C400), 155.01 (C2), 150.05
(C20), 148.01 (C6), 143.01 (C4), 140.76 (C50), 139.50 (C100),
136.51 (C1000 ), 135.17 (C200), 130.14 (C600), 129.88 (C3000 ;4000 ;5000 ),
126.88 (C3,300,500), 124.90 (C2000 ), 117.08 (C6000 ), 115.11 (C5),
112.52 (C40), 108.37 (C30), 20.54 ACH3.
2.3.4. Synthesis of 4-(3-ﬂuorophenyl)-2-(furan-2-yl)-6-p-
tolylpyridine [L4]
It has been synthesized using the pyridinium salt of 2-acetyl
furan and enone prepared by the reaction between m-
ﬂuorobenzaldehyde and p-methylacetophenone. Yield: 59%,
mp: 90 C, Anal. Calc. for: C22H16FNO (329.37): Calc. (%):
C, 80.23; H, 4.90; N, 4.25. Found (%): C, 80.24; H, 4.88; N,
4.27. 1H NMR (CDCl3, 400 MHz): d (ppm) 8.075–8.054 (d,
2H, H200,600), 7.839–7.836 (d, 1H, H3), 7.774–7.771 (d, 1H,
H5), 7.597–7.593 (d, 1H, H5000 ), 7.566–7.454 (complex, 3H,
H2000 ;4000 ;6000 ), 7.350–7.330 (d, 2H, H300,500), 7.283–7.274 (d-poor
resolved, 1H, H50), 7.211–7.164 (t-poor resolved, 1H, H40),
6.610–6.592 (dd, 1H, H30), 2.459 (s, 3H, ACH3). IR (KBr,
4000–400 cm1): 3063, v(CAH)ar stretching; 1551, v(C‚C);
1489, v(C‚N); 1381, pyridine skeleton; 1222, v(CAF). 13C
NMR (CDCl3, 100 MHz) d (ppm): 157.11 (C300), 154.1 (C2),
149.96 (C20), 148.51 (C6), 143.88 (C40), 139.07 (C100), 137.05
(C50), 130.98 (C1000 ), 129.43 (C3000 ;5000 ), 128.86 (C4000 ), 127.08
(C500;2000 ;6000 ), 123.32 (C600), 116.45 (C3,5), 114.06 (C40), 112.67
(C200,400), 109.07 (C30), 20.67 ACH3.
2.3.5. Synthesis of 4-(3-chlorophenyl)-2-(furan-2-yl)-6-p-
tolylpyridine [L5]
It has been synthesized using the pyridinium salt of 2-acetyl
furan and enone prepared by the reaction between
m-chlorobenzaldehyde and p-methylacetophenone. Yield:Please cite this article in press as: Patel, M.N. et al., Synthesis of heterocyclic compou
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(%): C, 76.41; H, 4.66; N, 4.05. Found (%): C, 76.40; H,
4.68; N, 4.04. 1H NMR (CDCl3, 400 MHz): d (ppm) 8.072–
8.052 (d, 2H, H200,600), 7.910–7.901(t, 1H, H3), 7.820–7.817 (d,
1H, H5), 7.756–7.753 (d, 1H, H2000 ), 7.700–7.681 (d, 1H, H6000 ),
7.630–7.595 (complex, 2H, H3000 ;5000 ), 7.433–7.394 (t, 1H, H40),
7.348–7.329 (d, 2H, H300,500), 7.248–7.275 (d-poor resolved,
1H, H50), 6.609–6.597 (dd, 1H, H30), 2.458 (s, 3H, ACH3). IR
(KBr, 4000–400 cm1): 3063, v(CAH)ar stretching; 1551,
v(C‚C); 1489, v(C‚N); 1381, pyridine skeleton band; 1225,
v(CACl); 864,748, (m-substituted ring). 13C NMR (CDCl3,
100 MHz) d (ppm): 156.54 (C300), 154.02 (C2), 150.00 (C20),
143.51 (C6), 139.05 (C4), 138.08 (C100), 135.50 (C50), 132.01
(C1000 ;4000 ), 130.00 (C3000 ;5000 ), 128.47 (C500 ;2000 ;6000 ), 126.03 (C200,400,600),
123.40 (C3,5), 116.50 (C40), 115.17 (C30), 21.44 ACH3.
2.3.6. Synthesis of 4-(3-bromophenyl)-2-(furan-2-yl)-6-p-
tolylpyridine [L6]
It has been synthesized using the pyridinium salt of 2-acetyl
furan and enone prepared by the reaction between m-
bromobenzaldehyde and p-methylacetophenone. Yield: 38%,
mp: 88 C, Anal. Calc. for C22H16BrNO (390.27): Calc. (%):
C, 67.71; H, 4.13; N, 3.59. Found (%): C, 67.75; H, 4.14; N,
3.58. 1H NMR (CDCl3, 400 MHz): d (ppm) 8.073–8.053 (d,
2H, H200,600), 7.830–7.827 (d, 1H, H3), 7.765–7.750 (dd-poor
resolved, 2H2000 ;6000 ), 7.660–7.634 (complex, 1H, H40), 7.596–
7.594 (dd-poor resolved, 1H, H5), 7.480–7.464 (complex, 2H,
H3000 ;5000 ), 7.349–7.329 (d, 2H, H300,500), 7.288–7.284 (d-poor
resolved, 1H, H50), 6.610–6.597 (dd, 1H, H30), 2.458 (s, 3H,
ACH3). IR (KBr, 4000–400 cm
1): 3063, v(CAH)ar stretching;
1543, v(C‚C); 1497, v(C‚N); 1381, pyridine skeleton band;
1369, v(CABr); 813,733, (m-substituted ring). 13C NMR
(CDCl3, 100 MHz) d (ppm): 158.01 (C300), 154.52 (C2), 149.97
(C20), 148.81 (C6), 143.10 (C4), 139.11 (C100), 136.66 (C50),
130.09 (C1000 ), 129.54 (C3000 ;5000 ), 128.44 (C4000 ), 127.58 (C500;2000 ;6000 ),
122.67 (C600) 116.40 (C3,5). 114.88 (C200,400), 112.32 (C40),
109.06 (C30), 20.91 ACH3.
2.4. Synthesis of complexes
A ruthenium precursor [RuCl3(PPh3)3] was prepared by reﬂux-
ing the methanolic solution of RuCl33H2O and PPh3 (1:3) in
presence of conc. HCl for 1 h. The obtained reddish brown
precipitate was ﬁltered and dried under vacuum.
2.4.1. Synthesis of [Ru(L1)(PPh3)2Cl2] (I)
It has been synthesized by reﬂuxing the solution of ruthenium
precursor [RuCl3(PPh3)3] in toluene (0.1 mmol) with the
methanolic solution of ligand 4-(4-ﬂuorophenyl)-2-(furan-2-
yl)-6-p-tolylpyridine [L1] (0.1 mmol) in presence of LiCl as a
reducing agent (0.4 mmol in methanol) and Et3N (0.1 mmol
in methanol) for 4 h. The resulting solution has been concen-
trated to half of its volume and the product has been separated
by adding small amount of pet ether (60:80). The obtained
blackish brown product was washed with methanol, toluene
and dried under vacuum (Scheme 2). Yield: 12.5%, mp:
272.2 C, Anal. Calc. for: C58H46Cl2FNOP2Ru (1025.91):
Calc. (%): C, 67.90; H, 4.52; N, 1.37; Ru, 9.85. Found (%):
C, 67.84; H, 4.53; N, 1.45; Ru(gravimetrically), 9.80. UV–Vis (In
DMSO): k (nm) (e, M1 cm1): (In DMSO): 550 (450), 385
(4365), 275 (23,850). Conductance: 11 O1 cm2 mol1.nds and its applications. Arabian Journal of Chemistry (2015), http://dx.doi.org/
Scheme 2 Reaction scheme for the synthesis of complexes.
4 M.N. Patel et al.2.4.2. Synthesis of [Ru(L2)(PPh3)2Cl2] (II)
It has been synthesized using ligand 4-(4-chlorophenyl)-2-
(furan-2-yl)-6-p-tolylpyridine. Yield: 11.92%, mp: 256.1 C,
Anal. Calc. for: C58H46Cl3NOP2Ru (1042.37): Calc. (%): C,
66.83; H, 4.45; N, 1.34; Ru, 9.70. Found (%): C, 67.00; H,
4.43; N, 1.31; Ru(gravimetrically), 9.78. UV–Vis kmax (nm) (In
DMSO): UV–Vis (In DMSO): k (nm) (e, M1 cm1): (In
DMSO): 562 (380), 410 (5732), 272 (17,650). Conductance:
24 O1 cm2 mol1.2.4.3. Synthesis of [Ru(L3)(PPh3)2Cl2] (III)
It has been synthesized using the ligand 4-(4-bromophenyl)-2-
(furan-2-yl)-6-p-tolylpyridine. Yield: 9.9%, mp: 284.5 C, Anal.
Calc. for: C58H46BrCl2NOP2Ru (1086.82): Calc. (%): C, 64.10;
H, 4.27; N, 1.29; Ru, 9.30. Found (%): C, 67.24; H, 4.23; N,
1.23; Ru(gravimetrically), 9.35. UV–Vis (In DMSO): k (nm) (e,
M1 cm1): 582 (260), 398 (7340), 273 (11,440). Conductance:
7 O1 cm2 mol1.2.4.4. Synthesis of [Ru(L4)(PPh3)2Cl2] (IV)
It has been synthesized using the ligand 4-(3-ﬂuorophenyl)-2-
(furan-2-yl)-6-p-tolylpyridine. Yield: 13.4%, mp: 287.8 C,
Anal. Calc. for: C58H46Cl2FNOP2Ru (1025.91): Calc. (%): C,
67.90; H, 4.52; N, 1.37; Ru, 9.85. Found (%): C, 67.82; H,
4.50; N, 1.43; Ru(gravimetrically), 9.87. UV–Vis (In DMSO): k
(nm) (e, M1 cm1): 574 (387), 408 (5540), 270 (20,980).
Conductance: 14 O1 cm2 mol1.2.4.5. Synthesis of [Ru(L5)(PPh3)2Cl2] (V)
It has been synthesized using the ligand 4-(3-chlorophenyl)-2-
(furan-2-yl)-6-p-tolylpyridine. Yield: 13.5%, mp: 268.4 C,
Anal. Calc. for: C58H46Cl3NOP2Ru (1042.37): Calc. (%): C,
66.83; H, 4.45; N, 1.34; Ru, 9.70. Found (%): C, 66.90; H,
4.40; N, 1.30; Ru(gravimetrically), 9.63. UV–Vis (In DMSO): k
(nm) (e, M1 cm1): 563 (387), 389 (6252), 272 (16,440).
Conductance: 32 O1 cm2 mol1.Please cite this article in press as: Patel, M.N. et al., Synthesis of heterocyclic compou
10.1016/j.arabjc.2015.06.0312.4.6. Synthesis of [Ru(L6)(PPh3)2Cl2] (VI)
It has been synthesized using the ligand 4-(3-bromophenyl)-2-
(furan-2-yl)-6-p-tolylpyridine. Yield: 9.0%, mp: 264.1 C, Anal.
Calc. for: C58H46BrCl2NOP2Ru (1086.82): Calc. (%): C, 64.10;
H, 4.27; N, 1.29; Ru, 9.30. Found (%): C, 67.15; H, 4.29; N,
1.25; Ru(gravimetrically), 9.26. UV–Vis (In DMSO): k (nm) (e,
M1 cm1): 558 (270), 392 (8120), 275 (15,427). Conductance:
19 O1 cm2 mol1.
2.5. Broth dilution method – an in vitro antibacterial study
The MIC informs about the degree of resistance of certain bac-
terial species toward the test compounds. MIC was performed
by serially twofold dilution of the test compound added to two
Gram(+ve) (Bacillus subtilis and Serratia marcescens) and three
Gram(ve) (Escherichia coli, Pseudomonas aeruginosa and
Staphylococcus aureus) and incubated at optimum temperature
for 24 h. If after 24 h bacterial growth is observed double of
the previously added concentration was taken for the test com-
pounds in tube and incubated for 24 h again. A concentration
at which no visible growth of bacteria is observed in the tubes
is regarded as minimum inhibitory concentration (MIC) at
which bacteria cannot defend against the test compounds.
2.6. DNA binding mode study
Binding mode of complex on interacting to DNA can be inves-
tigated by the alteration occurred in the absorption spectral
titration. This titrimetric analysis was performed by varying
the concentration of the HS–DNA with the addition of
100 lL of its aliquots in each successive addition in reference
cell and sample cell, keeping the complex concentration
constant, with the due correction for the absorbance of
HS–DNA alone. Spectra were recorded after 10 min of
incubation (Usharani et al., 2013).
Further the conﬁrmation of binding mode was done from
the viscosity measurement technique. An increase in viscosity
of native DNA upon binding of complexes is regarded as diag-
nostic feature of an intercalation process. The binding mode ofnds and its applications. Arabian Journal of Chemistry (2015), http://dx.doi.org/
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solution of 200 lM in Ubbelohde viscometer maintained in
constant thermometric bath. The time for DNA alone (to)
and for successive addition of the complex (t) were monitored.
2.7. BSLA – In vitro cytotoxicity assay
All the complexes were screened for in vitro toxicity using the
protocol of Mayer et al., as an initial step for the discovering
new drug. This method allows the use of fewer amounts of test
compounds and permits a large number of samples and
dilutions within a shorter time for analysis. From these stock
solutions of 1000 lg/mL; a set of 2, 4, 8, 12, 16 and
20 lg/mL was prepared. Three such replicates for each test
compounds along with the control containing DMSO alone
were prepared. After 24 h the number of survivals was counted
(Meyer et al., 1982). A graph of log of concentration of
samples was plotted against percentage of mortality of nauplii
(Islam et al., 2007). The LC50 value is the antilogarithm of
[complex] corresponding to the 50% mortality.
2.8. DNA nuclease proﬁle
Gel electrophoresis technique is widely used to study the cleav-
age of DNA by the action of test compounds. Isolated pUC19
DNA was subjected to agarose gel electrophoresis to investi-
gate the cleavage ability of ruthenium(II) complexes. An ali-
quot of 10 lL pUC19 DNA and 5 lL ruthenium(II)
complexes (1–6) were kept for incubation at 37 C for 4 h
and electrophoresed after addition of bromophenol blue for
2 h at 100 V on 1% agarose gel using Tris–acetic acid–
EDTA (TAE) buffer (pH 7.2). Ethidium bromide was added
to TAE buffer as a staining agent. After electrophoresis the
gel was photographed under UV illuminator. Quantiﬁcation
of DNA cleavage in terms of% cleavage is achieved from the
gel electrophoresis experiment.
3. Results and discussion
3.1. Electronic spectra and magnetism
The electronic spectra of all the complexes were obtained using
DMSO as a solvent. Three distinct bands are observed in the
range of 240–800 nm. The band in the range of 270–275 nm
is the characteristic intra ligand charge transfer band as the
extinction coefﬁcient is found to be higher than 10,000 unit,
which corresponds to the p–p* transition of ligands. The band
around 385–410 nm is due to metal to ligand charge transfer
band as the extinction coefﬁcient fall in the range of 1000–
10,000. The peak around 550–582 nm is due to d–d transitionTable 1 IR spectra of complexes.
Sr. no. m(C‚N)ar (cm
1) m(C‚C)ar (cm
1) m(CAH)ar (cm

(I) 1512 1549 3029
(II) 1506 1546 3040
(III) 1518 1548 3038
(IV) 1518 1554 3038
(V) 1504 1552 3044
(VI) 1514 1556 3057
Please cite this article in press as: Patel, M.N. et al., Synthesis of heterocyclic compou
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(Balasubramanian et al., 2007). The d–d transition is weakly
intense on the spectrum as they are Laporte forbidden. The
ground state of Ru(II) in an octahedral ﬁeld (t2g
6 conﬁguration)
is 1Alg. The excited states corresponding to t2g
5 eg
1 conﬁguration
are 3Tlg,
3T2g,
1T1g and
1T2g in increasing order of energy.
Thus, one should expect four transitions (Gunasekaran
et al., 2012). But all the transitions are not observed in the
actual spectrum as their intensities are very low. The electronic
spectrum of complex-(I) is represented in the supplementary
material. The magnetic moment of all the complexes is found
to be zero indicating the absence of unpaired electron in a
low-spin d6 – conﬁguration (t2g
6 ) for Ru(II) ion in octahedral
environment.3.2. Infrared spectroscopic characterization of complexes
IR spectral data of free ligands (Section 2.3) are compared
with their respective ruthenium(II) complexes (Table 1) to con-
ﬁrm whether the ligand has coordinated to ruthenium(II) ion
or not. The peaks corresponding to the ring stretching frequen-
cies of m(C‚N) of ligands (1427–1497 cm1) were shifted to
higher frequencies upon complexation (1504–1518 cm1) indi-
cating the coordination of the heterocyclic nitrogen atoms to
metal ion (Reddy and Shilpa, 2011). Bands observed in the
of range 1546–1556 cm1 are assigned as m(C‚C)ar. The
(CAH)ar. stretching bands are observed in the range of 3029–
3057 cm1. Bands observed in the range of 547–567 cm1
and 446–464 cm1 are assigned due to m(RuAN) and
m(RuAO) stretching vibration, respectively.
3.3. Thermogravimetric decomposition analysis of complexes
Fig. 1 shows the TG curve for complex-(I) obtained at a heat-
ing rate of 10 C per minute in the temperature range of 0–
900 C under N2 atmosphere. No decomposition up to
130 C suggests the absence of water molecule in the complex.
First mass loss (6.93%) in the temperature range of 130–
240 C corresponds to loss of chlorine atoms. Second mass loss
(51.11%) in the range of 30–590 C corresponds to the loss of
triphenylphosphine moiety. The third mass loss (32.09%) in
the range of 660–780 C corresponds to the loss of neutral
bidentate ligand, thus leaving behind metal oxide as a residue.
3.4. Mass spectra
The mass spectrum of complex-(I) (Fig. 2) shows that molecu-
lar ion peaks at m/z= 1025.09, 1027.01 and 1029.05 are
assigned to (M+), (M + 2), and (M+ 4), due to the presence1) m(RuAN) (cm1) m(RuAO) (cm1) PPh3 (cm
1)
554 446 1450, 1039, 691
549 459 1451, 1034, 694
548 464 1451, 1037, 689
567 450 1448, 1029, 695
550 458 1429, 1024, 686
547 460 1428, 1022, 684
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Figure 1 Thermogram of complex-I.
Figure 2 LC–MS spectrum of complex-I.
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Table 2 Binding constant (Kb) value of the synthesized
complexes.
Sr. no Complexes Kb · 105 (M1) %
Hypochromism
1 [Ru(PPh3)2(L
1)Cl2] (I) 2.60 27.35
2 [Ru(PPh3)2(L
2)Cl2] (II) 1.72 25.50
3 [Ru(PPh3)2(L
3)Cl2] (III) 1.18 20.47
4 [Ru(PPh3)2(L
4)Cl2] (IV) 0.889 18.79
5 [Ru(PPh3)2(L
5)Cl2] (V) 0.318 16.66
6 [Ru(PPh3)2(L
6)Cl2] (VI) 0.474 16.66
Synthesis and applications of heterocyclic compounds 7of two chlorine atoms. The peak observed at m/z= 990.12 is
due to loss of one chlorine atom. The peak at 955.19 is due
to the loss of second chlorine atom. Several other fragments
at 898.00, 748.09, 696.05, 693.12, 661.11, 626.08, 431.01,
364.02, 329.07 and 262.07 m/z value are observed, which
attributed to fragments associated with complex.
3.5. Broth dilution method – an in vitro antibacterial study
From the result represented in the supplementary material, it is
concluded that complex-(I) is more potent than the rest of the
synthesized complexes. The MIC value of the synthesized
complexes is found to be higher than the reference ligands
and metal salt, which symbolizes a very superior biological
control of bacteria by the synthesized complexes.
3.6. DNA binding mode study
Binding strength of the complexes with DNA is ascertained by
UV–Vis absorption titrations, examining the changes in the
absorbance of the ligand-centered bands and metal-to-ligand
charge transfer bands. Quantiﬁcation of DNA binding
strength is made from Kb values obtained from the ratio of
slope to intercept in the graph of [DNA]/(ea–ef) versus
[DNA] represented in the supplementary material. The per-
centage hypochromism of the complexes is obtained using
the equation (Af–Ab)/Af, where Af is the absorbance of fully
free form of DNA while Ab is the absorbance of completely
bound form in DNA in an experiment. In Fig. 3 hypochro-
mism with red shift is observed suggesting the intercalating
mode of binding and the Kb values along with % hypochro-
mism for the complexes are represented in Table 2. The Kb val-
ues for the complexes are found in the order of 104–105 and
change in hypochromism of the complexes is found in the
range of 16–27%. The values of observed hypochromism
and redshift of around 3–4 nm suggests the intercalative mode
of binding of complexes (Liu et al., 2008). Obtained Kb value is
found higher than [Ru(dmp)2(ipbp)]
+2 (dmp = 2,9-dimethyl-
1,10-phenanthroline, ipbp = 3-(1H-imidazo[4,5-f][1,10]phe
nanthrolin-2-yl)-4H-1-banzopyran-2-one) (7.58 · 103 M1)Figure 3 Absorption spectra of complex-I with increasing
concentration of HS–DNA in phosphate buffer Inset: Plots of
[DNA]/(ea–ef) versus [DNA] for the titration of DNA with
ruthenium(III) complexes.
Please cite this article in press as: Patel, M.N. et al., Synthesis of heterocyclic compou
10.1016/j.arabjc.2015.06.031Liu et al., 1999, but lower than the classical intercalators
[Ru(bpy)2(pip)]
2+ (pip = 2-phenylimidazo[4,5-f][1,10]phenan
throline) (4.70 · 105 M1) Xie et al., 2013 and
[Ru(dmb)2(addppn)](ClO4)2 (dmb = 4,4
0-dimethyl-2,20-bipyri
dine, addppn = acenaphtheno[1,2-b]-1,4-diazabenzo[i]dipyr
ido[3,2-a:20,30-c]phenazine) (4.78 · 105 M1) Liu et al., 2008.
Viscosity measurement technique solely cannot determine
the binding mode of the complex and is used along with the
absorption titration measurement to deduce the binding mode.
From the average ﬂow time g/g0 is calculated and plotted
against [DNA]/[complex]. In Fig. 4 viscosity of DNA solution
increases upon the addition of complexes in varying concentra-
tion. From the result of absorption and viscometric studies, it
is concluded that complexes bind to DNA via intercalative
binding mode.3.7. BSLA – in vitro cytotoxicity assay
In the brine shrimp lethality bioassay (BSLA), complexes show
positive results indicating that the complexes are biologically
active. The mortality rate of nauplii is found to increase with
increasing concentration of sample. The graph of% mortality
versus log conc. and the graph of LC50 values of synthesized
complexes are represented in Figs. 5 and 6 respectively.
From the graph, it can be observed that LC50 values of
complexes are found in the range of 6.76–19.50 lg/mL.Figure 4 Effect on relative viscosity of DNA under the inﬂuence
of increasing amount of complexes at 27 ± 0.1 C in phosphate
buffer (Na2HPO4/NaH2PO4, pH 7.2).
nds and its applications. Arabian Journal of Chemistry (2015), http://dx.doi.org/
Figure 5 % mortality against the log conc. of the complexes.
Figure 6 LC50 values of the synthesized complexes.
Figure 7 Cleavage of pUC19 plasmid DNA under the inﬂuence
of ruthenium complexes. Lane 1, DNA control; Lane 2, RuCl3Æ
3H2O; Lane 3, [Ru(L
1)(PPh3)2Cl2]; Lane 4, [Ru(L
2)(PPh3)2Cl2];
Lane 5, [Ru(L3)(PPh3)2Cl2]; Lane 6, [Ru(L
4)(PPh3)2Cl2]; Lane 7,
[Ru(L5)(PPh3)2Cl2]; and Lane 8, [Ru(L
6)(PPh3)2Cl2].
Table 3 Gel electrophoresis cleavage data of complexes.
Sr. no Complexes % OC % LC % SC % Cleavage
1 Control 13.1 – 86.9 –
2 RuCl33H2O 32.3 – 67.8 21.97
3 [Ru(PPh3)2(L
1)Cl2] (I) 75.2 14.7 10.2 88.26
4 [Ru(PPh3)2(L
2)Cl2] (II) 68.5 10.7 20.2 76.75
5 [Ru(PPh3)2(L
3)Cl2] (III) 68.4 15.8 15.7 81.93
6 [Ru(PPh3)2(L
4)Cl2] (IV) 79.1 9.6 11.3 86.99
7 [Ru(PPh3)2(L
5)Cl2] (V) 71.9 10.4 17.7 79.63
8 [Ru(PPh3)2(L
6)Cl2] (VI) 61.2 15.7 23.0 61.09
8 M.N. Patel et al.3.8. DNA nuclease proﬁle
The DNA cleavage can occur by two major pathways, i.e.,
hydrolytic and oxidative (Rabindra and Shilpa, 2010). (a) In
hydrolytic DNA cleavage, phosphodiester bond undergoes
cleavage to generate fragments which can be subsequently
referred. Hydrolytic cleavage which started in a modest way
of converting supercoil (SC) form of DNA to the open-
circular (OC) form and last in linear (L) form, is now being
used for identifying the % of cleavage as a function of concen-
tration of nuclease. (b) Oxidative DNA cleavage involves
either oxidation of the deoxyribose moiety by abstraction of
sugar hydrogen or oxidation of nucleobases. The general
mechanism of cleavage of DNA is represented in the supple-
mentary material. Fig. 7 represents the cleavage of DNA tak-
ing place from supercoiled (Form I) to open circular (Form
III) followed by its scission to linear (Form II). A control
experiment using DNA alone does not show any signiﬁcant
cleavage of DNA (Lane 1). A slight cleavage is observed when
RuCl33H2O was added to DNA (Lane 2). A signiﬁcant cleav-
age of supercoiled form to open circular form is observed
(Lane 3–8). The % cleavage data for all the complexes are rep-
resented in Table 3. The result clearly suggests that all the com-
plexes cause the efﬁcient scission of pUC19 DNA as compared
to the metal salt (RuCl33H2O).Please cite this article in press as: Patel, M.N. et al., Synthesis of heterocyclic compou
10.1016/j.arabjc.2015.06.0314. Conclusion
The result of various physicochemical techniques matches well
with the theoretically proposed structure of complexes. C, H
and N elemental analysis of the complexes matches well with
the theoretically proposed structure. Also the result of TGA
shows that the decomposition of complex taking place in var-
ious steps, supports the percentage data of ligands and PPh3,
indicating the coordination of these ligands to the central
metal atom. The different fragment peaks observed in LC–
MS spectra support the proof for the theoretically proposed
structure of the complexes. MIC of Ru(II) complexes is com-
pared with their respective ligands and it has been observednds and its applications. Arabian Journal of Chemistry (2015), http://dx.doi.org/
Synthesis and applications of heterocyclic compounds 9that the MIC values of complexes are found to be higher than
the corresponding ligands, which may be due to the chelate
effect causing increase in the lipophilicity of complexes com-
pared to ligands and hence complexes can easily penetrate
the lipid layer of bacterial cell wall and inhibit the bacterial
growth. Complex-I binds more efﬁciently to the DNA than
others and result of viscosity measurement reveals that com-
plexes bind to DNA via classical intercalation mode. From
the cytotoxicity study, it is found that LC50 values of the com-
plexes (10.93–16.78 lg/mL) are lower as compared to reference
standard potassium dichromate (32 lg/mL) suggesting that
complexes are signiﬁcantly toxic at low concentration as com-
pared to reference compound and their lower dose can inhibit
the 50% of population of test species as compared to the
higher dose required for the potassium dichromate. The
DNA cleavage study of pUC19 shows that all the complexes
show higher % cleavage data (61.09–88.26%) of supercoiled
form of pUC19 DNA compared to the reference compound
metal salt (21.97%) suggesting an efﬁcient cleavage of
pUC19 DNA by the synthesized complexes as compared to
the reference compounds metal salt.
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